Stem cell therapy for diabetes shows promise in pooled trial analysis, but evidence remains weak
A Bayesian network meta-analysis of 19 randomized trials finds combined mesenchymal stem/stromal cell plus mononuclear cell therapy lowered HbA1c and ...
